# Efficacy of INM004 in Children With STEC-HUS

> **NCT06389474** · PHASE3 · RECRUITING · sponsor: **Inmunova S.A.** · enrollment: 220 (estimated)

## Conditions studied

- Hemolytic-Uremic Syndrome

## Interventions

- **BIOLOGICAL:** INM004
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06389474
- **Lead sponsor:** Inmunova S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-05
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06389474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06389474, "Efficacy of INM004 in Children With STEC-HUS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06389474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*